Skip to main content
SpringerLink
Log in
Book cover

Human Retroviral Infections pp 109–142Cite as

Vaccine Approaches for Human T-cell Lymphotropic Virus Type I

  • Chapter

  • 113 Accesses

Part of the book series: Infectious Agents and Pathogenesis ((IAPA))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bum, P. A., Minna, J. D., and Gallo, R. C., 1980, Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, Proc. Natl. Acad. Sci. USA 77:7415–7419.

    Article  PubMed  CAS  Google Scholar 

  2. Yoshida, M., Miyoshi, I., and Hinuma, Y., 1992, Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease, Proc. Natl. Acad. Sci. USA 79:2031–2035.

    Article  Google Scholar 

  3. Manns, A., and Blattner, W. A,, 1991, The epidemiology of the human T-cell lymphotrophic virus type I and type 11: Etiologic role in human disease, Transfusion 31:67–75.

    Article  PubMed  CAS  Google Scholar 

  4. Gessain, A., and de The, G., 1996, in: Advances in Virus Research (K. Maranorosch, F. A. Murphy, and A. J. Shatkin, eds.), Academic Press, New York.

    Google Scholar 

  5. Vernant, J.-C., Maurs, L., Gessain, A., Barin, F., Gout, O., Delaporte, K., Sanhadji, K., Buisson, G., and de The, G., 1987, Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: A clinical and seroepidemiologic study of 25 cases, Ann. Neurol. 21:123–130.

    Article  PubMed  CAS  Google Scholar 

  6. Osame, M., Matsumoto, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Tara, M., and Igata, A., 1987, Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells, Ann. Neurol. 21:117–122.

    Article  PubMed  CAS  Google Scholar 

  7. Osame, M., Usuku, K., Izumo, S., Ijuchi, N., Amatani, H., Igata, A., Matsumoto, M., and Tara, M., 1986, HTLV-1 associated myelopathy, a new clinical entity, Lancet 1:1031–1032.

    Article  PubMed  CAS  Google Scholar 

  8. Mann, D., DeSantis, P., Mark, G., Pfeifer, A., Newman, M., Gibbs, N., Popovic, M., Sarngadharan, M., Gallo, R. C., Clark, J., and Blattner, W. A., 1987, HTLV-I-associated B-cell CLL: Indirect role for retrovirus in leukemogenesis, Ann. N. Y. Acad. Sci. 236:1103–1106.

    CAS  Google Scholar 

  9. Nakada, K., Kohakura, M., Komoda, H., and Hinuma, Y., 1984, High incidence of HTLV antibody in carriers of Strongyloides stercoralis, Lancet 1:663.

    Google Scholar 

  10. Katsuki, T., Katsuki, K., Imai, J., and Hinuma, Y., 1987, Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-1): Impairment of T-cell control of Epstein-Barr virus-infected B-cells, Jpn. J. Cancer Res. (Gann) 78:639–642.

    CAS  Google Scholar 

  11. Matsuzaki, H., Asou, N., Kawaguchi, Y., Hata, H., Yoshinaga, T., Kinuwaki, E., Ishii, T., Yamaguchi, K., and Takasuki, K., 1990, Human T-cell leukemiavirus type 1 associated with small cell lung cancer, Cancer 66:1763–1768.

    Article  PubMed  CAS  Google Scholar 

  12. Asou, N., Kumagai, T., Uekihara, S., Ishii, M., Sato, M., Sakai, K., Nishimura, H., Yamaguchi, K., and Takatsuki, K., 1986, HTLV-I seroprevalence in patients with malignancy, Cancer 58:903–907.

    Article  PubMed  CAS  Google Scholar 

  13. Taguchi, H., Kobayashi, M., and Miyoshi, I., 1991, Immunosuppression by HTLV-I infection, Lancet 337:308–309.

    Article  Google Scholar 

  14. Welles, S. L., Tachibana, N., Okayama, A., Shioiri, S., Ishihara, S., Murai, K., and Mueller, N. E., 1994, Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematological status, Int. J. Cancer 56:337–340.

    Article  PubMed  CAS  Google Scholar 

  15. Legrande, L., Hanchard, B., Fletcher, V., Cranston, B., and Blattner, W., 1990, Infective dermatitis of Jamaican children: A marker for HTLV-I infection, Lancet 3361345–1347.

    Article  Google Scholar 

  16. Ijichi, S., Matsuda, T., Maruyama, I., Izumihara, T., Kojima, K., Niimura, T., Maruyama, Y., Sonoda, S., Yoshida, A., and Osame, M., 1990, Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier, Ann Rheum. Dis. 49:718–721.

    Article  PubMed  CAS  Google Scholar 

  17. Mochizuki, M., Watanabe, T., Yamaguchi, K., Yoshimura, K., Nakashima, S., Shirao, M., Araki, S., Takatsuki, R, Mori, S., and Miyata, N., 1992, Uveitis associatedwith human T-cell lymphotropic virus type I, Am. J. Ophthalmol. 114123–129.

    PubMed  CAS  Google Scholar 

  18. Mochizuki, M., Watanabe, T., Yamaguchi, K., Takatsuki, R, Yoshimura, K, Shirao, M., Nakashima, S., Mori, S., Araki, S., and Miyata, N., 1991, HTLV-I uveitis: A distinct clinical entity caused by HTLV-I, Jpn. J. Cancer Res. 83:236–239.

    Google Scholar 

  19. Mochizuki, M., Tajima, K., Watanabe, T., and Yamaguchi, K., 1994, Human T lymphotropic virus type 1 uveitis, Br.J. Ophthalmol. 78149–154.

    Article  PubMed  CAS  Google Scholar 

  20. Gessain, A., and Gout, O., 1992, Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I), Ann Intern. Med. 117:933–946.

    PubMed  CAS  Google Scholar 

  21. Kaplan, J. E., Osame, M., Kubota, H., Nishitani, H., Maeda, Y., Khabbaz, R. F., and Janssen, R., 1990, The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I,J. Acquired Immune Defic. Syndr. 3:1096–1101.

    CAS  Google Scholar 

  22. Mueller, N., 1991, The epidemiology of HTLV-I infection, Cancer Causes Control Pap. Symp. 2:37–52.

    Article  CAS  Google Scholar 

  23. Tajima, K., and The T-and B-Cell Malignancy Study Group and Coauthors, 1990, The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features, Int. J.Cancer 45:237–243.

    Article  PubMed  CAS  Google Scholar 

  24. Bomford, R., Kazanji, M., and de The, G., 1997, Vaccine against human T cell leukemia-lymphoma virus type I: Progress and prospects, AIDS Res. Hum. Retrovir. 12:403–405.

    Google Scholar 

  25. Kinoshita, K., Amagasaki, T., Hino, S., Doi, H., Yamanouchi, K., Ban, N., Momita, S., Ikeda, S., Kamihira, S., Ichimaru, M., Katamine, S., Miyamoto, T., Tsuji, Y., Ishimaru, T., Yamabe, T., Ito, M., Kamura, S., and Tsuda, T., 1987, Milk-borne transmission of HTLV-I from carrier mothers to their children, Jpn. J, Cancer Res. (Gann) 78:674–680.

    CAS  Google Scholar 

  26. Narita, M., Shibata, M., Togashi, T., and Koga, Y., 1991, Vertical transmission of human T cell leukemia virus type I, J. Infect. Dis. 163:204.

    PubMed  CAS  Google Scholar 

  27. Stuver, S. O., Tachibana, N., Okayama, A., and Mueller, N. E., 1996, Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki, Japan, J. Infect. Dis. 173:584–591.

    PubMed  CAS  Google Scholar 

  28. Williams, A. E., Fang, C. T., Slamon, D., Poiesz, B. J., Sandler, S., Darr, W., Shulman, G., McGowan, E., Douglas, D., Bowman, R., Peetoom, F., Kleinman, S., Lenes, B., and Dodd, R., 1988, Seroprevalence and epidemiological correlates of HTLV-I infection in US. blood donors, Ann. N. Y. Acad. Sci. 240:643–649.

    CAS  Google Scholar 

  29. Lee, H. H., Swanson, P., Rosenblatt, J. D., Chen, I. S., Sherwood, W. C., Smith, D. E., Tegtmeier, G. E., Fernando, L. P., Fang, C. T., and Osame, M., 1991, Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors, Lancet 337:1435–1439.

    Article  PubMed  CAS  Google Scholar 

  30. Lee, H. H., Weiss, S. H., Brown, L. S., Mildvan, D., Shorty, V., Saravolatz, L., Chu, A., Ginzburg, H. M., Markowitz, N., and Des, J. D., 1990, Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA, J. Infect. Dis. 162:347–352.

    PubMed  CAS  Google Scholar 

  31. Lee, H., Swanson, P., Shorty, V., Zack, J., Rosenblatt, J. D., and Chen, I. S. Y., 1989, High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans, Ann. N. Y. Acad. Sci. 244:471–476.

    CAS  Google Scholar 

  32. Stuver, S., Tachibana, S., Okayama, A., Shioiri, S., Tsunetoshi, Y., Tsuda, K., and Mueller, N., 1993, Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: An initial report from the Miyazaki Cohort Study, J. Infect. Dis. 167:57–65.

    PubMed  CAS  Google Scholar 

  33. Dekaban, G. A., King, E., Waters, D., and Rice, G., 1992, Nucleotide sequence analysis of an HTLV-I isolate from a Chilean patient with HAM/TSP, AIDS Res. Hum. Retrovir. 8:1201–1207.

    PubMed  CAS  Google Scholar 

  34. Power, C., Weinshenker, B. G., Dekaban, G. A., Kaufman, J. C. E., and Rice, G. P. A., 1991, Pathological and molecular biologcal features of a myelopathy associated with HTLV-I infection, Can.J. Neurol. Sci. 18:352–355.

    PubMed  CAS  Google Scholar 

  35. Dekaban, G. A., Inwood, M., Waters, D., Drouin, J., and Teitel, J., 1992, Absence of human T-lymphotropic virus types I and II infection in an Ontario hemophilia population, Transfusion 32:513–516.

    Article  PubMed  CAS  Google Scholar 

  36. Picard, F. J., Coulthart, M. B., Oger, J., King, E. E., Kim, S., Arp, J., Rice, G. P. A., and Dekaban, G. A., 1995, Human T-lymphotropic virus type I (HTLV-I) in coastal natives of British Columbia: Phylogenetic affinities and possible origins, J. Virol. 69:7248–7256.

    PubMed  CAS  Google Scholar 

  37. The HTLV European Research Network, 1996, Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe, J. Acquired Immune Defic. Syndr. 13:68–77.

    Google Scholar 

  38. Schechter, M., Moulton, L. H., and Harrison, L. H., 1997, HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-1 and HIV-1, J. Acquired Immune Defic. Syndr. 15308–311.

    CAS  Google Scholar 

  39. Schechter, M., Harrison, L. H., Halsey, N. A., Trade, G., Santino, M., Moulton, L. H., and Quinn, T. C., 1994, Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers in HIV disease progression, JAMA 271:353–357.

    Article  PubMed  CAS  Google Scholar 

  40. Yamamoto, N., Okada, M., Koyanagi, Y., Kannagi, M., and Hinuma, Y., 1982, Transformation of human leukocytes by cocultivation with an adult T cell leukemia producer cell line, Ann. N. Y. Acad. Sci. 217:737–739.

    CAS  Google Scholar 

  41. Okochi, K., and Sato, H., 1986, Transmission of adult T-cell leukemia virus (HTLV-I) through blood transfusion and its prevention, AIDS Res. 2:S157–S161.

    PubMed  Google Scholar 

  42. Fan, N., Gavalchin, J., Paul, B., Wells, R, Lane, M. J., and Poiesz, B. J., 1992, Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I, J. Clin. Microbiol. 30:905–910.

    PubMed  CAS  Google Scholar 

  43. Clapham, P., Nagy, K., Cheingsong-Popov, R., Exley, M., and Weiss, R., 1983, Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line, Ann. N.Y. Acad. Sci. 222:1125–1127.

    CAS  Google Scholar 

  44. Macchi, B., Popovic, B., Allavena, P., Ortaldo, J., Gallo, R. C., and Bonmassar, E., 1987, In vitro susceptibility of different human T-cell subpopulations and resistance of large granular lymphocytes to HTLV-I infection, Int.J. Cancer 40:1–6.

    Article  PubMed  CAS  Google Scholar 

  45. Macchi, B., Popovic, M., Allavena, P., Rossi, P., Gallo, R. C., and Bonmassar, E., 1987, Differential susceptibility of human mononuclear cells to infection with HTLV-I, Int. J. Tiss. React. 9:195–198.

    CAS  Google Scholar 

  46. Koyanagi, Y., Itoyama, Y., Nakamura, N., Takamatsu, K., Kira, J., Iwamasa, T., Goto, I., and Yamamoto, N., 1993, In vivo infection of human T-cell leukemia virus type I in non-T cells, Virology 196:25–33.

    Article  PubMed  CAS  Google Scholar 

  47. Ho, D. D., Rota, T. R., and Hirsch, M. S., 1984, Infection of human endothelial cells by human T-lymphotropic virus type I, Proc. Natl. Acad. Sci. USA 81:7588.

    Article  PubMed  CAS  Google Scholar 

  48. Hoffman, P. M., Dhib-Jalbut, S., Mikovits, J. A., Robbins, D. S., Wolf, A. L., Bergey, G. K., Lohrey, N. C., Weislow, O. S., and Ruscetti, F. W., 1992, Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures, Proc. Natl. Acad. Sci.USA 89:11784–11788.

    Article  PubMed  CAS  Google Scholar 

  49. Suga, T., Kameyama, T., Shimotohno, R, Matsumura, M., Tanaka, H., Kushida, S., Ami, Y., Uchida, M., Uchida, IC, and Miwa, M., 1991, Infection of rats with HTLV-I: A small-animal model for HTLV-I carriers, Int. J. Cancer 49:764–769.

    Article  PubMed  CAS  Google Scholar 

  50. Cockerell, G. L., Lairmore, M. D., De, B., Rovnak, J., Hartley, T. M., and Miyoshi, I., 1990, Persistent infection of rabbits with HTLV-I: Patterns of anti-viral antibody reactivity and detection of virus by gene amplification, Int. J. Cancer 45:127–130.

    Article  PubMed  CAS  Google Scholar 

  51. Eguchi, T., Kubonishi, I., Daibata, M., Yano, S., Imamura, J., Ohtsuki, Y., and Miyoshi, I., 1988, Serial transplantation of an HTLV-I-transformed hamster lymphoid cell line into hamsters, Int. J. Cancer 41:868–872.

    PubMed  CAS  Google Scholar 

  52. Seto, A., Kawanishi, M., Matsuda, S., Ogawa, R, Eguchi, T., and Miyoshi, I., 1987, Induction of preleukemic stage of adult T cell leukemia-like disease in rabbits, Jpn. J. Cancer Res. (Gann) 78:1150–1155.

    CAS  Google Scholar 

  53. Yoshiki, T., Kondo, N., Chubachi, T., Tateno, M., Togashi, T., and Itoh, T., 1987, Rat lymphoid cell lines with HTLV-I production. III. Transmission of HTLV-I into rats and analysis of cell surface antigens associated with HTLV-I, Arch. Virol. 97:181–196.

    Article  PubMed  CAS  Google Scholar 

  54. Nakamura, H., Hayami, M., Ohta, Y., Ishikawa, R, Tsujimoto, H., Kiyokawa, T., Yoshida, M., Sasagawa, A., and Honjo, S., 1987, Protection of cynomolgus monkeys against infection by human T-cell leukemia virus type I by immunization with viral env gene products produced in Escherichia coli, Int. J. Cancer 40:403–407.

    Article  PubMed  CAS  Google Scholar 

  55. Truckenmiller, M. E., Kulaga, H., Gugel, E., Dickerson, D., and Kindt, T. J., 1989, Evidence for dual infection of rabbits with the human retroviruses HTLV-I and HIV-I, Res. Immunol. 140:527–544.

    Article  PubMed  CAS  Google Scholar 

  56. Ishiguro, N., Abe, M., Seto, R, Sakurai, H., Ikeda, H., Wakisaka, A., Togashi, T., Tateno, M., and Yoshiki, T., 1992, A rat model of human T lymphocyte virus type 1 (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats, J. Exp. Med. 176:981–989.

    Article  PubMed  CAS  Google Scholar 

  57. Tanaka, Y., Tanaka, R., Terada, E., Koyanagi, Y., Miyano-Kurosaki, N., Yamamoto, N., Baba, E., Nakamura, M., and Shida, H., 1994, Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro andin vivo by peptide immunization, J. Virol. 68:6323–6331.

    PubMed  CAS  Google Scholar 

  58. Kalyanaraman, V. S., Sarngadharan, M. G., Bunn, P. A., Minna, J. D., and Gallo, R. C., 1981, Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus, Nature 294271–273.

    Google Scholar 

  59. Manns, A., Murphy, E. L., Wilks, R., Haynes, G., Figueroa, J., Hanchard, B., Barnett, M., Drummond, J., Waters, D., Cerney, M., Seals, J., Alexander, S. S., Lee, H., and Blattner, W. A., 1991, Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients, Blood 77:896–905.

    PubMed  CAS  Google Scholar 

  60. Sinclair, A., Habeshaw, J., Muir, L., Chandler, P., Forster, S., Cruickshank, K., and Dalgleish, A. G., 1988, Antibodydependent cell-mediated cytotoxicity: Comparison between HTLV-I and HIV-I assays, AIDS 2:465–472.

    Article  PubMed  CAS  Google Scholar 

  61. Clapham, P., Nagy, K, and Weiss, R., 1984, Pseudotypes of human T-cell leukemia virus types 1 and 2: Neutralization by patient sera, Proc. Natl. Acad. Sci. USA 81:2886–2889.

    Article  PubMed  CAS  Google Scholar 

  62. Nagy, K., Clapham, P., Cheingsong-Popov, R., and Weiss, R., 1983, Human T-cell leukemia virus type I: Induction of syncytia and inhibition by patients’ sera, Int. J.Cancer 32:321–328.

    Article  PubMed  CAS  Google Scholar 

  63. Jacobson, S., Shida, H., McFarlin, D. E., Fauci, A., and Koenig, S., 1990, Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease, Nature 348:245–248.

    Article  PubMed  CAS  Google Scholar 

  64. Parker, C. E., Daenke, S., Nightingale, S., and Bangham, C. R., 1992, Activated, HTLV-I-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis, Virology 188:628–636.

    Article  PubMed  CAS  Google Scholar 

  65. Kunitomi, T., Takigawa, H., Sugita, M., Nouno, S., Suemune, M., Inoue, M., Kodani, N., Oda, M., and Ikeda, M., 1990, Antibodydependent cellular cytotoxicity and natural killer activity against HTLV-I infected cells, Acta Paediatr. Jpn. 32:16–19.

    PubMed  CAS  Google Scholar 

  66. Zhang, X., Yang, L., Ho, D., Kuritzkes, D., Chen, I. S. Y., Ching, W., Chen, Y. M., and Schooley, R., 1992, Human T lymphotropic virus types I-and 11-specific antibody-dependent cellular cytotoxicity: Strain specificity and epitope mapping, J. Infect. Dis. 165:805–812.

    PubMed  CAS  Google Scholar 

  67. Komurian, F., Pelloquin, F., and de The, G., 1991, In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies, J. Virol. 65:3770–3778.

    PubMed  CAS  Google Scholar 

  68. Hoshino, H., Nakamura, T., Tanaka, Y., Miyoshi, I., and yanagihara, R., 1993, Functional conservation of the neutralizing domains on the external envelope glycoprotein of cosmopolitan and Melanesian strains of human T cell leukemia/lymphoma virus type I, J. Infect. Dis. 168:1368–1378.

    PubMed  CAS  Google Scholar 

  69. Benson, J., Tschachler, E., Gessain, A., Yanagihara, R., Gallo, R. C., and Franchini, G., 1994, Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands, AIDS Res. Hum. Retrovir. 10:91–96.

    PubMed  CAS  Google Scholar 

  70. Levy, J. A., 1998, HIV and the Pathogenesis ofAIDS, 2nd ed., ASM Press, Chapter 7, pp. 137–174.

    Google Scholar 

  71. Hoshino, H., Nakamura, T., Tanaka, Y., Miyoshi, I., and yanagihara, I., 1993, Functional conservation of the neutralizing domains on the external envelope glycoprotein of cosmopolitan and Melanesian strains of human T cell leukemia/lymphomavirus type 1, J. Infect. Dis. 168:1368–1373.

    PubMed  CAS  Google Scholar 

  72. Tanaka, Y., Ishii, R, Sawada, T., Ohtsuki, Y., Hoshino, H., Yanagihara, R., and Miyoshi, I., 1993, Prophylaxis against a Melanesian variant of human T-lymphotropic virus type-1 (HTLV-I) in rabbits using HTLV-I immune globulin from asymptomatically infected Japanese carriers, Blood 82:3664–3667.

    PubMed  CAS  Google Scholar 

  73. Jarrett, O., 1996, Efficacy of recombinant feline leukemia virus vaccines, AIDS Res. Hum. Retrovir. 12:435–436.

    PubMed  CAS  Google Scholar 

  74. Hoover, E. A., Mullins, J. I., Chu, H. J., and Wasmoen, T. L., 1997, Development and testing of an inactivated feline leukemia virus vaccine, Semin. Vet. Med. Surg. (Small Anim.) 10:238–243.

    Google Scholar 

  75. Earl, P., Moss, B., Morrison, B., Wehrly, K., Nishio, J., and Chesebro, B., 1986, T-Lymphotropic priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant, Ann. N.Y. Acad. Sci. 234:728–731.

    CAS  Google Scholar 

  76. Miyazawa, M., Nishio, J., and Chesebro, B., 1992, Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene, J. Virol. 66:4497–4507.

    PubMed  CAS  Google Scholar 

  77. Marx, P. A., Pederson, N. C., Lerche, N. W., Osborn, K. G., Lowenstine, L. J., Lacker, A. A., Maul, D. H., Kwang, H.-S., Kluge, J. D., Zaiss, C. P., Sharpe, V., Spinner, A. P., Allison, A. C., and Gardner, M. B., 1986, Isolation of a new serotype of simian acquired immune deficiency syndrome type D retrovirus from Celebes black macaques (Macaca nigra) with immune deficiency and retroperitoneal fibromatosis, J. Virol. 60:431–435.

    PubMed  CAS  Google Scholar 

  78. Brody, B. A., Hunter, E., Kluge, J. D., Lasarow, R., Gardner, M. B., and Marx, P. A., 1992, Protection of macaques against infection with simian type D retrovirus (SRV-1) by immunization with recombinant vaccine virus expressing the envelope glycoproteins of either SRV-1 or Mason-Pfizer monkey virus (SRV-3), J. Virol. 66:3950–3954.

    PubMed  CAS  Google Scholar 

  79. Sarin, P., and Gallo, R. C., 1998, Lymphotropic retroviruses of animals and man, Adv. Vet. Sci. Comp. Med. 32227–250.

    Google Scholar 

  80. Hopkins, S. G., and DiGiacomo, R. F., 1997, Natural transmission of bovine leukemiavirus in dairy and beef cattle, Vet. Clin. North Am. Food Anim. Pract. 13:107–128.

    PubMed  CAS  Google Scholar 

  81. Ohishi, K., Suzuki, H., Yamamoto, T., Maruyama, T., Miki, K., Ikawa, Y., Numakunai, S., Okada, K., Ohshima, K., and Sugimoto, M., 1991, Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: Association with cell-mediated immunity, J. Gen. Virol. 72:1887–1892.

    Article  PubMed  CAS  Google Scholar 

  82. Callebaut, I., Voneche, V., Mager, A., Fumiere, O., Krchnak, V., Merza, M., Zavada, J., Mammerickx, M., Burny, A., and Portetelle, D., 1993, Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51, J. Virol. 67:5321–5327.

    PubMed  CAS  Google Scholar 

  83. Gatei, M. H., Naif, H. M., Kumar, S., Boyle, D. B., Daniel, R. C. W., Good, M. F., and Lavin, M. F., 1993, Protection of sheep against bovine leukemiavirus (BLV) infection byvaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: Correlation of protection with CD4+ T-cell response to gp51 peptide 51–70, J. Virol. 67:1803–1810.

    PubMed  CAS  Google Scholar 

  84. Gatei, M. H., Good, M. F., Daniel, R. C. W., and Lavin, M. F., 1993, T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: Relevance to vaccine development, J. Virol. 67:1796–1802.

    PubMed  CAS  Google Scholar 

  85. Ohishi, K., and Ikawa, Y., 1996, T cell-mediated destruction of bovine leukemia virus-infected peripheral lymphocytes by bovine leukemia virus env-vaccinia recombinant vaccine, AIDS Res. Hum. Retrovir 12:393–398.

    PubMed  CAS  Google Scholar 

  86. Tanaka, Y., Tozawa, H., Koyanagi, Y., and Shida, H., 1990, Recognition of human T cell leukemia virus type I (HTLV-I) gag and pXgene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells, J. Immunol. 144:4202–4211.

    PubMed  CAS  Google Scholar 

  87. Noguchi, Y., Tateno, M., Kondo, N., Yoshiki, T., Shida, H., Nakayama, E., and Shiku, H., 1989, Rat cytotoxic T lymphocytes against human T-lymphotrophic virus type I-infected cells recognize gag gene and env gene encoded antigens, J. Immunol. 143:3737–3742.

    PubMed  CAS  Google Scholar 

  88. Hori, M., Ami, Y., Kushida, S., Kobayashi, M., Uchida, K., Abe, M., and Miwa, M., 1995, Intrauterine transmission of human T-cell leukemia virus type I in rats, J. Virol. 69:1302–1305.

    PubMed  CAS  Google Scholar 

  89. Hirose, S., Kotani, S., Uemura, Y., Fujishita, M., Taguchi, H., Ohtsuki, Y., and Miyoshi, I., 1988, Milk-borne transmission of human T-cell leukemia virus type-I in rabbits, Virology 162:487–489.

    Article  PubMed  CAS  Google Scholar 

  90. Yoshiki, T., Tateno, M., Sakurai, H., Ishiguro, N., Ikeda, H., and Wakisaka, A., 1992, A rat model of HTLV-I infection, Gann Monogr. Cancer Res. 39205–216.

    Google Scholar 

  91. Lairmore, M. D., Roberts, B. D., Frank, D., Rovnak, J., Weiser, M. G., and Cockerell, G. L., 1991, Comparative biological responses of rabbits infected with human T-lymphotropic virus type I isolates from patients with lymphoproliferative and neurodegenerative disease, Int. J. Cancer 49:1–7.

    Article  Google Scholar 

  92. Ibrahim, F., Fiette, L., Gessain, A., Buissan, N., de The, G., and Bonford, R., 1994, Infection of rats with human T-cell leukemia virus type-I susceptibility of inbred strains, antibody response and provirus location, Int. J. Cancer 58:446–451.

    Article  PubMed  CAS  Google Scholar 

  93. Kazanji, M., Bomford, R., Bessereau, J.-L., and de The, G., 1997, Expression and immunogeneity in rats of recombinant adenovirus 5 DNA plasmids and vaccinia virus containing the HTLV-I env gene, Int. J. Cancer 71:300–307.

    Article  PubMed  CAS  Google Scholar 

  94. Kazanji, M., Moreau, J. P., Mahieux, R., Bonnemains, B., Bomford, R., Gessain, A., and de The, G., 1997, HTLV-I infection in squirrel monkeys (Saimiri sciureus) using autologous, homologous, or heterologous HTLV-I-transformed cell lines, Virology 231:258–268.

    Article  PubMed  CAS  Google Scholar 

  95. Neurath, A. R., Adamowicz, P., Kent, S. B. H., Riottot, M. M., Strick, N., Parker, R, Offensperger, W., Petit, M. A., Wahl, S., Budkowska, A., Girard, M., and Pillot, J., 1986, Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein, Mol. Immunol. 23:991–997.

    Article  PubMed  CAS  Google Scholar 

  96. Petit, M. A., Maillard, P., Capel, F., and Pillot, J., 1986, Immunochemical structure of the hepatitis B surface antigen vaccine-11. Analysis of antibody responses in human sera against the envelope proteins, Mol. Immunol. 23:511–523.

    Article  PubMed  CAS  Google Scholar 

  97. Waters, J., Pignatelli, S., Galpin, K., Ishihara, K., and Thomas, H. C., 1986, Virus-neutralizing antibodies to hepatitis B virus: The nature of an immunogenic epitope on the S gene peptide, J. Gen. Virol. 67:2467–2473.

    Article  PubMed  CAS  Google Scholar 

  98. Ogawa, K., Matsuda, S., and Seto, A., 1989, Induction of leukemic infiltration by allogeneic transfer of HTLV-I-transformed T cells in rabbits, Leuk. Res. 13:399–406.

    Article  PubMed  CAS  Google Scholar 

  99. Seto, A., Kawanishi, M., Matsuda, S., Ogawa, R, and Miyoshi, I., 1988, Adult T cell leukemia-like disease experimentally induced in rabbits, Jpn. J. Cancer Res. (Gann) 79:335–341.

    CAS  Google Scholar 

  100. Kushida, S., Mizusawa, H., Matsumura, M., Tanaka, H., Ami, Y., Hori, M., Yagami, K., Kameyama, T., Tanaka, Y., Yoshida, A., Nyunoya, H., Shimotohno, K., Iwasaki, Y., Uchida, K., and Miwa, M., 1994, High incidence of HAM/TSP-like symptoms in WKA rats after administration of human T-cell leukemia virus type I-producing cells, J. Virol. 68:7221–7226.

    PubMed  CAS  Google Scholar 

  101. Kazanji, M., Ibrahim, F., Fiette, L., Bomford, R., and de The, G., 1997, Role of the genetic background of rats in infection by HTLV-I and HTLV-II and the development of associated diseases, Int.J. Cancer 73:131–136.

    Article  PubMed  CAS  Google Scholar 

  102. Ishihara, S., Tachibana, N., Okayama, A., Murai, R, Tsuda, K., and Mueller, N., 1992, Successful graft of HTLV-I-transformed human T-cells (MT-2) in severe combined immunodeficiency mice treated with anti-asialo GM-1 antibody, Jpn. J. Cancer Res. 83:320–328.

    PubMed  CAS  Google Scholar 

  103. Feuer, G., Zack, J. A., Harrington, W., Valderama, R., Rosenblatt, J. D., Wachsman, W., Baird, S. M., and Chen, I. S. Y., 1993, Establishment of human T-cell leukemiavirus type I T-cell lymphomas in severe combined immunodeficient mice, Blood 82:722–731.

    PubMed  CAS  Google Scholar 

  104. Schiedner, G., Morral, N., Parks, R. J., Wu, Y., Koopsmans, S. C., Langston, C., Graham, F. L., Beaudet, A. L., and Kochanek, S., 1998, Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity, Nature Genet. 18:180–183.

    Article  PubMed  CAS  Google Scholar 

  105. Sommerfelt, M., Williams, B., Clapham, P., Solomon, E., Goodfellow, P., and Weiss, R., 1988, Human T cell leukemia viruses use a receptor determined by human chromosome 17, Ann N Y. Acad. Sci. 242:1557–1560.

    CAS  Google Scholar 

  106. Ford, C. M., Arp, J., Palker, T. J., King, E., and Dekaban, G. A., 1992, Characterization of the antibody response to three different versions of the HTLV-I envelope protein expressed by recombinant vaccinia viruses: Induction of neutralizing antibody, Virology 191:448–455.

    Article  PubMed  CAS  Google Scholar 

  107. Arp, J., Ford, C. M., Palker, T. J., King, E., and Dekaban, G. A, 1993, Expression and immunogenicity of the entire human T cell leukaemia virus type I envelope protein produced in a baculovirus system, J. Gen. Virol. 74:211–222.

    Article  PubMed  CAS  Google Scholar 

  108. Blakeslee, J. R., McClure, M. H., Anderson, D. C., Bauer, R. M., Huff, L. Y., and Olsen, R. G., 1986, Chronic fatal disease in gorillas seropositive for simian T-lymphotropic virus I antibodies, CancerLett. 37:1–6.

    Google Scholar 

  109. Homma, T., Kanki, P. J., King, N. M., Hunt, R. D., O’Connell, M. J., Letvin, N. L., Daniel, M. D., Desrosiers, R. C., Yang, C. S., and Essex, M., 1984, Lymphoma in macaques: Association with virus of human T-lymphotropic family, Ann. N. Y. Acad. Sci. 225:716–718.

    CAS  Google Scholar 

  110. Tsujimoto, H., Noda, Y., Ishibishi, K., Nakamura, H., Fukasawa, M., Sakakibara, I., Sasagawa, M., Honjo, S., and Hayami, M., 1987, Development of adult T-cell leukemia-like disease in African green monkey associated with clonal integration of simian T-cell leukemia virus type I, Cancer Res. 47:269–274.

    PubMed  CAS  Google Scholar 

  111. Schatzl, H., Tschikobava, M., Rose, D., Voevodin, A., Nitschko, H., Sieger, E., Busch, U., von der Helm, K., and Lapin, B., 1993, The Sukhumi primate monkey model for viral lymphomogenesis: High incidence of lymphomas with presence of STLV-I and EBV-like virus, Leukemia 7(Suppl. 2):S86–S92.

    PubMed  Google Scholar 

  112. Shida, H., Tochikura, T., Sato, T., Konno, T., Hirayoshi, R, Seki, M., Ito, Y., Hatanaka, M., Hinuma, Y., Sugimoto, M., Takahashi-Nishimaki, F., Maruyama, T., Miki, K., Suzuki, K., Morita, M., Sashiyama, H., and Hayami, M., 1987, Effect of recombinant vaccinia viruses, EMBOJ. 6:3379–3384.

    CAS  Google Scholar 

  113. Takehara, N., Iwahara, Y., Uemura, Y., Sawada, T., Ohtsuki, Y., Hoshino, H., and Miyoshi, I., 1989, Effect of immunization on HTLV-I infection in rabbits, Int.J. Cancer 44:332–336.

    Article  PubMed  CAS  Google Scholar 

  114. Hakoda, E., Machida, H., Tanaka, Y., Morishita, N., Sawada, T., Shida, H., Hoshino, H., and Miyoshi, I., 1995, Vaccination for rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I, Int. J.Cancer 60:567–570.

    Article  PubMed  CAS  Google Scholar 

  115. Kataoka, R., Takehara, N., Iwahara, Y., Sawada, T., Ohtsuki, Y., Dawei, Y., Hoshino, H., and Miyoshi, I., 1990, Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits, Blood 76:1657–1661.

    PubMed  CAS  Google Scholar 

  116. Miyoshi, I., Takehara, N., Sawada, T., Iwahara, Y., Kataoka, R., Yang, D., and Hoshino, H., 1992, Immunoglobulin prophylaxis against HTLV-I in a rabbit model, Leukemia 6:24–26.

    PubMed  Google Scholar 

  117. Murata, N., Hakado, E., Machida, H., Ikezoe, T., Sawada, T., Hoshino, H., and Miyoshi, I., 1996, Prevention of human T-lymphotropic virus type I infection in Japanese macaques by passive immunization, Leukemia 10:1971–1974.

    PubMed  CAS  Google Scholar 

  118. Dezzutti, C. S., Frazier, D., Lafrado, L., and Olsen, R., 1990, Evaluation of a HTLV-I subunit vaccine in prevention of experimental STLV-I infection in Macaca nemestrina, J. Med. Primatol. 19:305–316.

    PubMed  CAS  Google Scholar 

  119. Dezzutti, C. S., Frazier, D., Huff, L., Stromberg, P., and Olsen, R., 1990, Subunit vaccine protects Macaca nemestrina (Pig-tailed Macaque) against simian T-cell lymphotropic virus type I challenge, CancerRes. 50:5687s–5691s.

    CAS  Google Scholar 

  120. Grassmann, R., Dengler, C., Muller-Fleckenstein, I., Fleckenstein, B., McGuire, K., Dokhelar, M. C., Sodroski, J., and Haseltine, W., 1989, Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimirivector, Proc. Natl. Acad. Sci. USA 86:3351–3355.

    Article  PubMed  CAS  Google Scholar 

  121. Franchini, G., Mulloy, J. C., Koralnik, I.J., Lo Monico, A., Sparkowski, J.J., Andresson, T., Goldstein, D. J., and Schlegel, R., 1993, The human T-cell leukemia/lymphotropic virus type I p121 protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase, J. Virol. 67:7701–7704.

    PubMed  CAS  Google Scholar 

  122. Vile, R. G., Schulz, T. F., Danos, 0. F., Collins, M. R, and Weiss, R., 1991, A murine cell line producing HTLV-I pseudotype virions carrying a selectable marker gene, Virology 180:420–424.

    Article  PubMed  CAS  Google Scholar 

  123. Wilson, C., Reitz, M., Okayama, H., and Eiden, M., 1989, Formation of infectious hybrid virions with Gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the gag and pol proteins of Moloney murine leukemia virus, J. Virol. 63:2374–2378.

    PubMed  CAS  Google Scholar 

  124. Denesvre, C., Carrington, C., Corbin, A., Takeuchi, Y., Cosset, F.-C., Schulz, T., Sitbon, M., and Sonigo, P., 1996, TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions, J. Virol. 70:4380–4386.

    PubMed  CAS  Google Scholar 

  125. Hu, S.-L., Abrams, K., Barber, G., Moran, P., Zarling, J., Langlois, A., Kuller, L., Morton, W., and Benveniste, R., 1992, Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160, Ann. N. Y. Acad. Sci. 255:456–459.

    CAS  Google Scholar 

  126. Franchini, G., Tartaglia, J., Markham, P., Benson, J., Fullen, J., Wills, J., Arp, J., Dekaban, G. A., Paoletti, E., and Gallo, R., 1995, Highly attenuated HTLV type I, poxvirus vaccines induce protection against a cell associated HTLV-I challenge in rabbits, AIDS Res. Hum. Retrovir. 11:307–313.

    PubMed  CAS  Google Scholar 

  127. Lubeck, M. D., Natuk, R., Myagkikh, M., Kalyan, N., Aldrich, R, Sinangil, F., Alipanah, S., Murthy, S. C. S., Chanda, P., Nigida, S. M., Markham, P., Zolla-Pazner, S., Steimer, R, Wade, M., Reitz, M. S., Arthor, L. O., Mizutani, S., Davis, A., Hung, P. P., Gallo, R. C., Eichberg, J, and Rober-Guroff, M., 1997, Long-term protection of chimpanzees against high-dose HIV-I challenge induced by immunization, Nature Med. 3:651–658.

    Article  PubMed  CAS  Google Scholar 

  128. Kim, J. J., Begarazzi, M. L., Trivedi, N., Hu, Y., Kazahaya, K., Wilson, D. M., Ciccarelli, R., Chaattergoon, M. A., Dang, R, Mahalingam, S., Chalin, A. A., Agagjanyan, M. G., Boyer, J. D., Wang, B., and Weiner, D. B., 1997, Engineering of in vivoimmune responses to DNA immunization via codelivery of costimulatory molecules genes, Nature Biotechnol. 15:651–646.

    Google Scholar 

  129. Fynan, E., Webster, R., Fuller, D., Haynes, J. R., Santoro, J., and Robinson, H., 1993, DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations, Proc. Natl. Acad. Sci. USA 90:11478–11482.

    Article  PubMed  CAS  Google Scholar 

  130. Ugen, K. E., Agadjanyan, M. G., Wang, B., Merva, M., Williams, W. V., and Weiner, D. B., 1994, Genetic immunization against HTLV-I, AIDS Res. Hum. Retrovir 10:445.

    Google Scholar 

  131. Agadjanyan, M. G., Wang, B., Nyland, S. B., Weiner, D. B., and Ugen, K. E., 1998, DNA plasmid based vaccination against the oncogenic human T cell leukemiavirus type I, Curr. Top. Microbiol. Immunol. 226:175–192.

    PubMed  CAS  Google Scholar 

  132. Boyle, J. S., Koniaras, C., and Lew, A. M., 1997, Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: Cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization, Int. Immunol. 9:1897–1906.

    Article  PubMed  CAS  Google Scholar 

  133. Ruegg, C., Monell, C., and Strand, M., 1989, Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lym-photropic virus types I and II, J. Virol. 63:3250–3256.

    PubMed  CAS  Google Scholar 

  134. Lafrado, L., Lewis, M., Mathes, I., and Olsen, R., 1987, Suppression of in vitro neutrophil function by feline leukaemia virus (FeLV) and purified FeLV-p15E, J.Gen.Virol. 68:507–513.

    Article  PubMed  CAS  Google Scholar 

  135. Shida, H., Tochikura, T., Sato, T., Konno, T., Hirayoshi, K., Seki, M., Ito, Y., Hatanaka, M., Hinuma, Y., Sugimoto, M., Takahashi-Nishimaki, F., Maruyama, T., Miki, K., Suzuki, R, Morita, M., Sashiyama, H., and Hayami, M., 1987, Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection, EMBOJ. 6:3379–3384.

    CAS  Google Scholar 

  136. Kageyama, S., Katsumoto, T., Taniguchi, R, Ismail, S. I., Shimmen, T., Sasao, F., Gao, M., Owatari, S., Wakamiya, N., Tsuchie, H., Ueda, S., and Kurimura, T., 1996, Neutralization of human immunodeficiency virus type I (HIV-I) with antibody from carriers’ plasma against HIV-1 protein p17, Acta Virol. 40:195–200.

    PubMed  CAS  Google Scholar 

  137. Papsidero, L. D., Sheu, M., and Ruscetti, F. W., 1989, Human immunodeficiency virus type-I-neutralizing monoclonal antibodies which react with p17 core protein, J. Virol. 63:267–272.

    PubMed  CAS  Google Scholar 

  138. Emini, E. A., Schleif, W. A., Quintero, J. C., Conard, P. G., Eichberg, J., Vlasuk, G. P., Lehman, E. D., Polokoff, M. A. Schaeffer, T. F., Schultz, L. D., Hofmann, K. J., Lewis, J. A., and Larson, V. M., 1990, Yeast-expressed p55 precursor core protein of human immuno-deficiency virus type 1 does not elicit protective immunity in chimpanzees, AIDS Res. Hum. Retrovir. 6:1247–1250.

    PubMed  CAS  Google Scholar 

  139. Buseyne, F., McChesney, M., Porrot, F., Kovarik, S., Guy, B., and Riviere, Y., 1993, Gagspecific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein, J. Virol. 67:694–702.

    PubMed  CAS  Google Scholar 

  140. Wiktor, S. Z., Pate, E. J., Murphy, E. L., Palker T.J., Champegnie, E., Ramlal, A., Cranston, B., Hanchard, B., and Blattner, W. A., 1993, Mother-to-child tranmission of human T-cell lymphotropic virus type I(HTLV-I) in Jamaica: Association with antibodies to envelope glycoprotein (gp46) epitopes. J. Acquired Immune Defic. Syndr. 6:1162–1167.

    CAS  Google Scholar 

  141. Green, J., Hinrichs, S. H., Vogel, J., and Jay, G., 1989, Exocrinopathy resembling Sjogren’s syndrome in HTLV-I tax transgenic mice, Nature 341:72–74.

    Article  PubMed  CAS  Google Scholar 

  142. Parker, C. E., Nightingale, S., Taylor, G. P., Weber, J., and Bangham, C. R., 1994, Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously, J. Virol. 68:2860–2868.

    PubMed  CAS  Google Scholar 

  143. Greene, W. C., Bohnlein, E., and Ballard, D. W., 1989, HIV-1, HTLV-I and normal T-cell growth: Transcriptional strategies and surprises, Immunol. Today 10:272–278.

    Article  PubMed  CAS  Google Scholar 

  144. Kelly, K., Davis, P., Mitsuya, H., Irving, S., Wright, J., Grassmann, R., Fleckenstein, B., Wano, Y., Greene, W. C., and Siebenlist, U., 1992, A high proportion of early response genes are constitutively activated in T cells by HTLV-I, Oncogene 7:1463–1470.

    PubMed  CAS  Google Scholar 

  145. Gartenhaus, R., Lunardi-Iskandar, Y., Berneman, Z., Reitz, M., Gallo, R. C., and Klotman, M., 1994, Soluble recombinant HTLV-Itax protein has proliferative effects on cells of lymphoid origin, J. Clin. Invest.:1–34.

    Google Scholar 

  146. Schonbach, C., Nokihara, K., Bangham, C. R., Kariyone, A., Karaki, S., Shida, H., Takatsu, K., Egawa, K., Weismuller, K., and Takiguchi, M., 1996, Identification of HTLV-I-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501transgenic mice, Virology 226:102–112.

    Article  PubMed  CAS  Google Scholar 

  147. Lal, R. B., Giam, C. Z., Coligan, J. E., and Rudolph, D. L., 1994, Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (Tax and Rex) in human T cell lymphotropic virus type I-associated myelopathy, J. Infect. Dis. 169:496–503.

    PubMed  CAS  Google Scholar 

  148. Kuga, T., Hattori, S., Yoshida, M., and Taniguchi, T., 1986, Expression of human T-cell leukemia virus type I envelope protein in Saccharomyces cerevisiae, Gene 44:337–340.

    Article  PubMed  CAS  Google Scholar 

  149. Arp, J., LeVatte, M., Rowe, J., Perkins, S., King, E., Leystra-Lantz, C., Foung, S. K., and Dekaban, G. A., 1996, A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: Expression of gp46 by the vaccinia virus/T7 polymerase system, J. Virol. 70:7349–7359.

    PubMed  CAS  Google Scholar 

  150. Hadlock, K. G., Rowe, J., Perkins, S., Bradshaw, P., Song, G.Y., Cheng, C., Yang, J., Gascon, R., Halmos, J., Rehman, S. M. M., McGrath, M. S., and Foung, S. K., 1997, Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46, J. Virol. 71:5828–5840.

    PubMed  CAS  Google Scholar 

  151. Palker, T. J., Tanner, M., Scearce, R., Streilein, R., Clark, M., and Haynes, B., 1989, Mapping of immunogenic regions of human T-cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46, J. Immunol. 142:971–978.

    PubMed  CAS  Google Scholar 

  152. Tanaka, Y., Tanaka, R., and Hoshino, H., 1994, Identification of a novel neutralization epitope on envelope gp46 antigen of human T-cell-leukemia virus-type-I1 (HTLV-II), Int, J. Cancer 59:655–660.

    Article  CAS  Google Scholar 

  153. Baba, E., Nakamura, M., Tanaka, Y., Kuroki, M., Itoyama, Y., Nakano, S., and Niho, Y., 1993, Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type I (HTLV-I) identified by human monoclonal antibodies, J. Immunol. 151:1013–1024.

    PubMed  CAS  Google Scholar 

  154. Palker, T. J., Riggs, E., Spragion, D., Muir, A., Scearce, R., Randall, R., McAdams, M., McKnight, A., Clapham, P., Weiss, R., and Haynes, B., 1992, Mapping of homologous, amino-terminal neutralizing regions of humanT-cell lymphotropic virustypeI and II gp46 envelope glycoproteins, J.Virol. 66:5879–5889.

    PubMed  CAS  Google Scholar 

  155. Manca, F., Li Pira, G., Fenoglio, D., Valle, M., Kunkl, A., Ferraris, A., Lancia, F., Saverino, D., Mortara, L., Balderas, R., Arp, J., Dekaban, G., Dalgleish, A., Lozzi, L., and Theofilopoulos, A., 1995, Recognition of human T-leukemia virus (HTLV-I) envelope by human CD4+ T-cell lines from HTLV-I seronegative individuals: Specificity and clonal heterogeneity, Blood 85:1547–1554.

    PubMed  CAS  Google Scholar 

  156. Bab, E., Nakamura, M., Ohkuma, K., Kira, J. I., Tanaka, Y., Nakano, S., and Niho, Y., 1995, A peptide based human T-cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies, J. Immunol. 154:399–412.

    Google Scholar 

  157. Ralston, S., Hoeprich, P., and Akita, R., 1989, Identification and synthesis of the epitope for a human monoclonal antibody which can neutralize human T-cell leukemia/lymphotropic virus type I, J. Biol. Chem. 264:16343–16346.

    PubMed  CAS  Google Scholar 

  158. Desgranges, C., Souche, S., Vernant, J. C., Smadja, D., Vahlne, A. and Horal, P., 1994, Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera, AIDSRes. Hum. Retrovir. 10:163–173.

    Article  CAS  Google Scholar 

  159. Lafrado, L., Lewis, M., Mathes, L., and Olsen, R., 1987, Suppression of in vitro neutrophil function by feline leukemia virus (FeLV) and purified FeLV-p15E, J.Gen.Virol. 68:507–513.

    Article  PubMed  CAS  Google Scholar 

  160. Tanaka, Y., Zeng, L., Shiraki, H., Shida, H., and Tozawa, H., 1991, Identification of a neutralization epitope on the envelope gp46 antigen of human T-cell leukemiavirus type I and induction of neutralizing antibody by peptide immunization, J.Immunol. 147:354–360.

    PubMed  CAS  Google Scholar 

  161. Jacobson, S., Reuben, J., Streilein, R., and Palker, T. J., 1991, Induction of CD4+ human T lymphotropic virus type-I-specific cytotoxic T lymphocytes from patients with HAM/TSP, J.Immunol. 146:1155–1162.

    PubMed  CAS  Google Scholar 

  162. Palker, T. J., Scearce, R., Copeland, T. D., Oroszlan, S., and Haynes, B., 1986, Gterminal region of human T cell lymphotropic virus type I (HTLV-I) p19 core protein is immunogenic in humans and contains an HTLV-I-specific epitope, J. Immunol. 136:2393–2397

    PubMed  CAS  Google Scholar 

  163. Noguchi, Y., Noguchi, T., Sato, T., Yokoo, Y., Itoh, S., Yoshida, M., Yoshiki, T., Akiyoshi, K., Sunamoto, J,, Nakayama, E., and Shiku, H., 1991, Priming for in vitro and in vivo anti-human T lymphotropic virus type I cellular immunity by virus-related protein reconstituted into liposome, J. Immunol. 146:3599–3603.

    PubMed  CAS  Google Scholar 

  164. Dokhelar, M. C., Pickford, H., Sodroski, J., and Haseltine, W., 1989, HTLV-I p27rex regulates gag and env protein expression, J. Acquired Immune Defic. Syndr. 2:431–440.

    CAS  Google Scholar 

  165. Schwartz, S., Felber, B., and Pavlakis, G., 1992, Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein, J.Virol. 66:150–159.

    PubMed  CAS  Google Scholar 

  166. Lal, R. B., Owen, S. M., Rudolph, D., and Levine, P. H., 1994, Sequence variation within the immunodominant epitope-coding region from the external glycoprotein of human T lymphotropic virus type II in isolates from Seminole indians, J. Infect. Dis. 169:407–411.

    PubMed  CAS  Google Scholar 

  167. Sonoda, S., Yashiki, S., Takahashi, K, Arhna, N., Daitoku, Y., Matsumoto, M., Matsumoto, T., Tara, M., Shinmyoszu, K, Sato, K., Inoko, H., Ando, A., and Tsuji, K, 1987, Altered HLA antigens expressed on T and B lymphocytes of adult T-cell leukemia/lymphoma patients and their relatives, Int. J.Cancer 40:629–634.

    Article  PubMed  CAS  Google Scholar 

  168. Haynes, B., 1993, Scientific and social issues of immunodeficiency virus vaccine develop ment, Ann. N.Y. Acad. Sci. 260:1279–1286.

    CAS  Google Scholar 

  169. Milich, D. R., and McLachlan, A., 1986, The nucleocapsid of hepatitis B virus is both a T-cell-independent antigen and a T-cell-dependent antigen, Ann. N.Y. Acad. Sci. 234:1398–1401.

    CAS  Google Scholar 

  170. Haynes, J. R., Cao, S. X., Rovinski, B., Sia, C., James, O., Dekaban, G. A., and Klein, M. H., 1991, Production of immunogenic HIV-I viruslike particles in stably engineered monkey cell lines, AIDS Res. Hum. Retrovir. 1:17–27.

    Google Scholar 

  171. Weiss, S. H., 1994, The evolving epidemiology of human T lymphotropic virus type II [editorial], J. Infect. Dis. 169:1080–1083.

    PubMed  CAS  Google Scholar 

  172. Calender, A., Gessain, A., Essex, M., and de The, G., 1984, Seroepidemiology of human T-cell leukemia virus in the French West Indies: Antibodies in blood donors and patients with lymphoproliferative diseases who do not have AIDS, Ann. N.Y. Acad. Sci. 437:175–176.

    Article  PubMed  CAS  Google Scholar 

  173. Lairmore, M. D., Roberts, B. D., Frank, D., Rovnak, J., Weiser, M. G., and Cockerell, G. L., 1992, Comparative biological responses of rabbits infected with human T-lymphotropic virus type I isolates from patients with lymphoproliferative and neurodegenerative disease, Int. J. Cancer 50:124–130.

    Article  PubMed  CAS  Google Scholar 

  174. Cockerell, G. L., Weiser, M. G., Rovnak, J., Wicks-Beard, B., Roberts, B. D., Post, A., Chen, I. S. Y., and Lairmore, M. D., 1991, Infectious transmission of human T-cell lymphotropic virus type II in rabbits, Blood 78:1532–1537.

    PubMed  CAS  Google Scholar 

  175. Abiad, H., and Hershow, R., 1997, Current understanding of HTLV-II and its role in disease, Infect. Med. 14:815–820.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gene Therapy and Molecular Virology Group, The John P. Robarts Research Institute, London, Ontario, Canada, N6A 5K8

    G. A. Dekaban, A. Peters & J. Arp

  2. Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada, N6A 5K8

    G. A. Dekaban, A. Peters & J. Arp

  3. Basic Research Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892

    G. Franchini

Authors
  1. G. A. Dekaban
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Arp
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Franchini
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of South Florida College of Medicine, Tampa, Florida

    Kenneth E. Ugen  & Herman Friedman  & 

  2. University of Pisa, Pisa, Italy

    Mauro Bendinelli

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Dekaban, G.A., Peters, A., Arp, J., Franchini, G. (2002). Vaccine Approaches for Human T-cell Lymphotropic Virus Type I. In: Ugen, K.E., Bendinelli, M., Friedman, H. (eds) Human Retroviral Infections. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-46819-0_6

Download citation

  • DOI: https://doi.org/10.1007/0-306-46819-0_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46222-1

  • Online ISBN: 978-0-306-46819-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation